F A Oliveira, R N de Almeida, M F Sousa, J M Barbosa-Filho, S A Diniz, I A de Medeiros
Index: Pharmacol. Biochem. Behav. 68 , 199-202 , (2001)
Full Text: HTML
A new tryptamine analogue, N-salicyloyltryptamine (STP), a potential central nervous system (CNS) depressant, was tested in the pentylenetetrazol (PTZ) and maximal electroshock (MES) models of epilepsy in mice. When administered concurrently, STP (100 mg/kg ip) significantly reduced the number of animals that exhibited PTZ-induced seizures and eliminated the extensor reflex of maximal electric-induced seizures test in 50% of the experimental animals. In addition, it showed protection in the PTZ test by diminishing the death rate.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
N-Salicyloyltryptamine
CAS:31384-98-2 |
C17H16N2O2 |
|
Occurrence and behavior of the chiral anti-inflammatory drug...
2014-12-01 [Environ. Toxicol. Chem. 33(12) , 2671-8, (2014)] |
|
Nanoemulsions as novel oral carriers of stiripentol: insight...
2015-01-01 [Int. J. Nanomedicine 10 , 4937-46, (2015)] |
|
Determination of natural and synthetic glucocorticoids in ef...
2015-09-01 [Environ. Sci. Pollut. Res. Int. 22 , 14127-35, (2015)] |
|
Microglia regulate blood clearance in subarachnoid hemorrhag...
2015-07-01 [J. Clin. Invest. 125 , 2609-25, (2015)] |
|
The effects of tympanomastoid paragangliomas on hearing and ...
2014-01-01 [Audiol. Neurootol. 19(5) , 342-50, (2014)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
